The Orthomyxoviridae are a family of RNA viruses that includes five
genera: Influenzavirus A, Influenzavirus B, Influenzavirus C, Thogotovirus and Isavirus. The first three genera contain
viruses that cause influenza in vertebrates, including birds
(see also avian influenza), humans, and other
mammals. Isoviruses infect salmon; thogotoviruses infect vertebrates and invertebrates, such as mosquitoes and sea lice.[1][2][3][4]
The three genera of Influenzavirus, which are identified by antigenic differences in their nucleoprotein and matrix protein infect vertebrates as
follows:[1]
Morphology
Structure of the influenza viron. The
hemagglutinin (HA) and
neuraminidase (NA) proteins are shown on the surface of the particle. The viral RNAs that make up the
genome are shown as red coils inside the particle and bound to Ribonuclear Proteins (RNPs).
The virions have envelopes and occur in pleomorphic and filamentous forms. In
general the virus's morphology is spherical with particles 50 to 120 nm in diameter, or
filamentous virions 20 nm in diameter and 200 to 300 (-3000) nm long. There are some 500 distinct spike-like surface projections
of the envelope each projecting 10 to 14 nm from the surface with some types (i.e. hemagglutininesterase (HEF)) densely dispersed over the surface, and with others (i.e.
hemagglutinin (HA)) spaced widely apart.
The major glycoprotein (HA) is interposed irregularly by clusters of neuraminidase (NA), with a ratio of HA to NA of about 4-5 to 1.
Lipoprotein membranes enclose the nucleocapsids;
nucleoproteins of different size classes with a loop at each end; the arrangement within the virion is uncertain. The
nucleocapsids are filamentous and fall in the range of 50 to 130 nm long and 9 to 15 nm in diameter. They have a helical
symmetry.
Nucleic Acid
Viruses of this family contain 7 to 8 segments of linear negative-sense
single stranded RNA.
The total genome length is 12000-15000 nucleotides (nt). The largest segment 2300-2500 nt;
of second largest 2300-2500 nt; of third 2200-2300 nt; of fourth 1700-1800 nt; of fifth 1500-1600 nt; of sixth 1400-1500 nt; of
seventh 1000-1100 nt; of eighth 800-900 nt. Genome sequence has terminal repeated sequences; repeated at both ends. Terminal
repeats at the 5'-end 12-13 nucleotides long. Nucleotide sequences of 3'-terminus identical; the same in genera of same family;
most on RNA (segments), or on all RNA species. Terminal repeats at the 3'-end 9-11 nucleotides long. Encapsidated nucleic acid is
solely genomic. Each virion may contain defective interfering copies.
Classification and nomenclature
In a phylogenetic-based taxonomy the
"RNA viruses" includes the "negative-sense ssRNA
viruses" which includes the Order "Mononegavirales", and the Family
"Orthomyxoviridae" (among others). The species and serotypes of Orthomyxoviridae are shown in the following
table.
Orthomyxoviridae Genera, Species, And Serotypes
| Genus |
Species (* indicates type
species) |
Serotypes or Subtypes |
Hosts |
| Influenzavirus A |
Influenza A virus (*) |
H1N1, H1N2, H2N2, H3N1, H3N2, H3N8, H5N1,
H5N2, H5N3, H5N8, H5N9, H7N1, H7N2, H7N3,
H7N4, H7N7, H9N2, H10N7 |
Human, pig, bird, horse |
| Influenzavirus B |
Influenza B virus (*) |
|
Human, seal |
| Influenzavirus C |
Influenza C virus (*) |
|
Human, pig |
| Isavirus |
Infectious salmon anemia virus (*) |
|
Atlantic salmon |
| Thogotovirus |
Thogoto virus (*) |
|
Tick, Mosquito, Mammal (including Human) |
| Dhori virus |
Batken virus
Dhori virus |
Types of influenza virus
There are three genera of influenza virus: Influenzavirus A, Influenzavirus B and Influenzavirus C. Each genus includes
only one species, or type: Influenza A virus, Influenza B virus, and Influenza C virus, respectively. Influenza A and C infect
multiple species, while influenza B almost exclusively infects humans.[5][6]
Influenza A
-
Influenza A viruses are further classified, based on the viral surface proteins hemagglutinin (HA or H) and neuraminidase (NA or N). Sixteen H
subtypes (or serotypes) and nine N subtypes of influenza A virus have been identified.
Diagram of influenza nomenclature.
Further variation exists; thus, specific influenza strain isolates are identified by a standard nomenclature specifying virus
type, geographical location where first isolated, sequential number of isolation, year of isolation, and HA and NA
subtype.[7][8]
Examples of the nomenclature are:
- A/Moscow/10/99 (H3N2)
- B/Hong Kong/330/2001
The type A viruses are the most virulent human pathogens among the three influenza types and causes the most severe disease.
The serotypes that have been confirmed in humans, ordered by the number of known human pandemic
deaths, are:
Influenza B
-
Influenza B virus is almost exclusively a human pathogen, and is less common than influenza A. The only other animal known to
be susceptible to influenza B infection is the seal.[11]
This type of influenza mutates at a rate 2-3 times lower than type A[12] and consequently is less genetically diverse, with only one influenza B serotype.[5] As a result of this lack of antigenic diversity, a degree of immunity to influenza B is usually acquired at an early age. However, influenza
B mutates enough that lasting immunity is not possible.[13] This reduced rate of antigenic change, combined with its limited host range (inhibiting cross
species antigenic shift), ensures that pandemics of influenza B do not occur.[14]
Influenza C
-
The influenza C virus infects humans and pigs, and can cause
severe illness and local epidemics.[15] However, influenza C is less common than the other types and usually seems to cause mild disease in
children.[16][17]
Structure and properties
- An in-depth example can be found at H5N1 genetic structure
The following applies for Influenza A viruses, although other influenza strains are
very similar in structure[18]:
The influenza A virus particle or virion is 80-120 nm in diameter and usually roughly spherical, although filamentous
forms can occur.[19] Unusually for a virus, the influenza
A genome is not a single piece of nucleic acid; instead, it contains eight pieces of segmented
negative-sense RNA (13.5 kilobases total), which encode 11 proteins (HA, NA, NP, M1, M2, NS1, NEP,
PA, PB1, PB1-F2, PB2).[20] The
best-characterised of these viral proteins are hemagglutinin and neuraminidase, two large glycoproteins found on the outside of the
viral particles. Neuraminidase is an enzyme involved in the release of progeny virus from
infected cells, by cleaving sugars that bind the mature viral particles. By contrast, hemagglutinin is a lectin that mediates binding of the virus to target cells and entry of the viral genome into the target
cell.[21] The hemagglutinin (H) and neuraminidase (N)
proteins are targets for antiviral drugs.[22] These proteins are also recognised by antibodies, i.e. they are
antigens.[10] The responses of antibodies to these proteins are used to classify the different
serotypes of influenza A viruses, hence the H and N in H5N1.
Infection and replication
Invasion and replication of the influenza virus. The steps in this process are discussed in the text.
Typically, influenza is transmitted from infected mammals through the air by coughs or sneezes, creating aerosols containing the virus, and from infected birds through their droppings. Influenza can also be transmitted by saliva, nasal secretions, feces and blood. Infections occur
through contact with these bodily fluids or with contaminated surfaces. Flu viruses can remain infectious for about one week at
human body temperature, over 30 days at 0 °C (32 °F), and indefinitely at very low temperatures (such as lakes in northeast Siberia). They can be inactivated easily by disinfectants and
detergents.[23][24][25]
The viruses bind to a cell through interactions between its hemagglutinin glycoprotein
and sialic acid sugars on the surfaces of epithelial
cells in the lung and throat (Stage 1 in infection figure).[26] The cell imports the virus by endocytosis. In the acidic
endosome, part of the haemagglutinin protein fuses the viral envelope with the vacuole's
membrane, releasing the viral RNA (vRNA) molecules, accessory proteins and RNA-dependent RNA
transcriptase into the cytoplasm (Stage 2).[27] These proteins and vRNA form a complex that is transported into the
cell nucleus, where the RNA-dependent RNA transcriptase begins transcribing complementary
positive-sense vRNA (Steps 3a and b).[28] The vRNA is
either exported into the cytoplasm and translated (step 4), or remains in the nucleus. Newly-synthesised viral proteins are
either secreted through the Golgi apparatus onto the cell surface (in the case of
neuraminidase and hemagglutinin, step 5b) or transported back into the nucleus to bind vRNA and form new viral genome particles
(step 5a). Other viral proteins have multiple actions in the host cell, including degrading cellular mRNA and using the released nucleotides for vRNA synthesis and also
inhibiting translation of host-cell mRNAs.[29]
Negative-sense vRNAs that form the genomes of future viruses, RNA-dependent RNA transcriptase,
and other viral proteins are assembled into a virion. Hemagglutinin and neuraminidase molecules cluster into a bulge in the cell
membrane. The vRNA and viral core proteins leave the nucleus and enter this membrane protrusion (step 6). The mature virus buds
off from the cell in a sphere of host phospholipid membrane, acquiring hemagglutinin and neuraminidase with this membrane coat
(step 7).[30] As before, the viruses adhere to the cell
through hemagglutinin; the mature viruses detach once their neuraminidase has cleaved
sialic acid residues from the host cell.[26]
After the release of new influenza virus, the host cell dies.
Because of the absence of RNA proofreading enzymes, the RNA-dependent RNA transcriptase
makes a single nucleotide insertion error roughly every 10 thousand nucleotides, which is the approximate length of the influenza
vRNA. Hence, nearly every newly-manufactured influenza virus will contain mutation in its genome.[31] The separation of the genome into eight separate segments of vRNA allows mixing
or reassortment of the genes if more than one variety of influenza virus has infected the same cell. The resulting
alteration in the genome segments packaged in to viral progeny confers new behavior, sometimes the ability to infect new host
species or to overcome protective immunity of host populations to its old genome (in which case it is called an antigenic shift).[10]
Sources
- ^ a b Büchen-Osmond, C.:Index of Viruses - Orthomyxoviridae
(2006). In: ICTVdB - The Universal Virus Database, version 4. Columbia University, New York, USA (2006).
- ^ Jones LD, Nuttall PA
(1989). "Non-viraemic transmission of Thogoto virus: influence of time and distance". Trans. R. Soc. Trop. Med. Hyg.
83 (5): 712-4. PMID 2617637.
- ^ Barry Ely (1999). Infectious Salmon Anaemia.
Mill Hill Essays. National Institute for Medical
Research. Retrieved on 2007-09-14.
- ^ Raynard RS, Murray
AG, Gregory A (2001). "Infectious salmon anaemia virus in wild fish from Scotland". Dis. Aquat. Org. 46 (2):
93-100. PMID 11678233.
- ^ a b Hay A, Gregory V, Douglas A, Lin Y (Dec 29 2001).
"The evolution of human influenza viruses." (PDF). Philos Trans R Soc Lond B Biol Sci
356 (1416): 1861-70. PMID 11779385.
- ^ Avian Influenza (Bird Flu). Centers for Disease Control and Prevention. Retrieved on 2007-09-15.
- ^ (2007) in Atkinson W,
Hamborsky J, McIntyre L, Wolfe S: Epidemiology and Prevention of Vaccine-Preventable Diseases, 10th ed., Washington DC: Centers for Disease
Control and Prevention.
- ^ Avian Influenza (Bird Flu): Implications for Human Disease. Center for Infectious Disease Research & Policy,
University of Minnesota (2007-06-27).
Retrieved on 2007-09-14.
- ^ Fouchier R, Schneeberger P, Rozendaal F,
Broekman J, Kemink S, Munster V, Kuiken T, Rimmelzwaan G, Schutten M, Van Doornum G, Koch G, Bosman A, Koopmans M, Osterhaus A
(2004). "Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress
syndrome.". Proc Natl Acad Sci U S A 101 (5): 1356-61. PMID 14745020.
- ^ a b c Hilleman M (Aug 19 2002). "Realities and enigmas of human viral influenza: pathogenesis, epidemiology and
control.". Vaccine 20 (25-26): 3068-87. PMID 12163258.
- ^ Osterhaus A, Rimmelzwaan G, Martina B,
Bestebroer T, Fouchier R (2000). "Influenza B virus in seals.". Science 288 (5468): 1051-3. PMID
10807575.
- ^ Nobusawa E, Sato K (Apr 2006). "Comparison
of the mutation rates of human influenza A and B viruses.". J Virol 80 (7): 3675-8. PMID
16537638.
- ^ Webster R, Bean W, Gorman O,
Chambers T, Kawaoka Y (1992). "Evolution and ecology of influenza A viruses.". Microbiol Rev 56 (1):
152-79. PMID 1579108.
- ^ Zambon M (Nov 1999). "Epidemiology and pathogenesis of
influenza.". J Antimicrob Chemother 44 Suppl B: 3-9. PMID 10877456.
- ^ Matsuzaki Y, Sugawara K, Mizuta K, Tsuchiya
E, Muraki Y, Hongo S, Suzuki H, Nakamura K (2002). "Antigenic and genetic characterization of influenza C viruses which caused two outbreaks in Yamagata City, Japan, in 1996
and 1998.". J Clin Microbiol 40 (2): 422-9. PMID 11825952.
- ^ Matsuzaki Y, Katsushima N, Nagai Y, Shoji
M, Itagaki T, Sakamoto M, Kitaoka S, Mizuta K, Nishimura H (May 1 2006). "Clinical features of influenza C virus infection in
children.". J Infect Dis 193 (9): 1229-35. PMID 16586359.
- ^ Katagiri S, Ohizumi A, Homma M (Jul 1983).
"An outbreak of type C influenza in a children's home.". J Infect Dis 148 (1): 51-6. PMID
6309999.
- ^ International Committee on Taxonomy of Viruses descriptions of: Orthomyxoviridae Influenzavirus B Influenzavirus C
- ^ International Committee on Taxonomy of Viruses. The Universal Virus Database,
version 4: Influenza A.
- ^ Ghedin E, Sengamalay N, Shumway
M, Zaborsky J, Feldblyum T, Subbu V, Spiro D, Sitz J, Koo H, Bolotov P, Dernovoy D, Tatusova T, Bao Y, St George K, Taylor J,
Lipman D, Fraser C, Taubenberger J, Salzberg S (Oct 20 2005). "Large-scale sequencing of human influenza reveals the dynamic
nature of viral genome evolution.". Nature 437 (7062): 1162-6. PMID 16208317.
- ^ Suzuki Y (2005). "Sialobiology of influenza: molecular
mechanism of host range variation of influenza viruses.". Biol Pharm Bull 28 (3): 399-408. PMID
15744059.
- ^ Wilson J, von Itzstein M (Jul 2003).
"Recent strategies in the search for new anti-influenza therapies.". Curr Drug Targets 4 (5): 389-408. PMID
12816348.
- ^ Suarez, D; Spackman E, Senne D, Bulaga L,
Welsch A, Froberg K (2003). "The effect of various disinfectants on detection of avian influenza virus by real time RT-PCR".
Avian Dis 47 (3 Suppl): 1091–5. PMID 14575118.
- ^ Avian Influenza (Bird Flu): Implications for Human Disease. Physical characteristics of influenza A viruses. UMN
CIDRAP.
- ^ Flu viruses
'can live for decades' on ice, NZ Herald, November 30, 2006.
- ^ a b Wagner R, Matrosovich M, Klenk H (May-Jun
2002). "Functional balance between haemagglutinin and neuraminidase in influenza virus infections.". Rev Med Virol
12 (3): 159-66. PMID 11987141.
- ^ Lakadamyali M, Rust M, Babcock H, Zhuang
X (Aug 5 2003). "Visualizing infection of individual influenza viruses.". Proc Natl Acad Sci U S A 100 (16):
9280-5. PMID 12883000.
- ^ Cros J, Palese P (Sep 2003). "Trafficking
of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses.". Virus Res 95
(1-2): 3-12. PMID 12921991.
- ^ Kash J, Goodman A, Korth M, Katze M (Jul
2006). "Hijacking of the host-cell response and translational control during influenza virus infection.". Virus Res
119 (1): 111-20. PMID 16630668.
- ^ Nayak D, Hui E, Barman S (Dec 2004).
"Assembly and budding of influenza virus.". Virus Res 106 (2): 147-65. PMID 15567494.
- ^ Drake J (May 1 1993). "Rates of
spontaneous mutation among RNA viruses.". Proc Natl Acad Sci U S A 90 (9): 4171-5. PMID 8387212.
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)